Overdose Review Team Act

Hozzl · 2022-12-29T23:48:36Z

Explore the details of Senate Bill 4091 Overdose Review Team Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/29/2022, 11:48 PM

Congressional Summary of S 4091

Overdose Review Team Act

This bill provides funding to the Department of Health and Human Services for grants that support drug overdose fatality review teams in states, Indian tribes, territories, and localities. These multidisciplinary teams track fatal and nonfatal drug overdoses that occur in the jurisdiction to identify relevant trends and patterns and recommend policies and practices for preventing and reducing drug overdoses.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 4091

Bill S 4091 is currently in the status of Bill Introduced since April 27, 2022. Bill S 4091 was introduced during Congress 117 and was introduced to the Senate on April 27, 2022. Bill S 4091's most recent activity was Read twice and referred to the Committee on Finance. as of April 27, 2022

Bipartisan Support of Bill S 4091

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 4091

Primary Policy Focus

Health

Alternate Title(s) of Bill S 4091

Overdose Review Team Act

A bill to amend part A of title XI of the Social Security Act to provide grants to States, units of local government, and Indian Tribes to establish, expand, or maintain Drug Overdose Fatality Review Teams.